MedTrace Logo

Absolute Flow for Ischemia With No Obstructive Coronary Arteries

NCT05825339 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 121

Last updated 2023-04-24

No results posted yet for this study

Summary

The main objective is to prospectively validate the capacity of continuous thermodilution coronary flow reserve (CFRflow) as a predictor of the presence of angina measured by SAQ7 in patients with INOCA at 3 months. Secondary objectives include identifying hemodynamic factors related to the persistence of angina at 3 and 12 months, identifying clinical factors associated with the persistence of angina, establishing the prevalence of patients with coronary microvascular dysfunction within the cohort of INOCA patients, identifying predictors of major cardiovascular events at 12 months, validating the pathological value of MMR and establishing the pathological value of AF measured in ml/min. The study also aims to evaluate the concordance between measures of the coronary microvascular function obtained by continuous thermodilution and bolus thermodilution, as well as their concordance with clinical characteristics.

Conditions

  • Coronary Microvascular Dysfunction
  • Coronary Microvascular Disease
  • Angina, Stable

Interventions

DIAGNOSTIC_TEST

Coronary Flow Reserve

Diagnostic of Microvascular Coronary Dysfunction using continuous thermodilution flow reserve

Sponsors & Collaborators

  • Spanish Society of Cardiology

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-01
Primary Completion
2024-04-30
Completion
2024-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05825339 on ClinicalTrials.gov